CIK 0001815974 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Anebulo Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ANEB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851170950
- Phone
- 737 203 5270
- Business address
- C/O ANEBULO PHARMACEUTICALS, INC., 1017 RANCH ROAD 620 SOUTH, SUITE 107, LAKEWAY, TX, 78734
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-04 | Cunningham, Richard Anthony Chief Executive Officer | Grant or award · Stock Option (right to buy) | +316,352 | 316,352 | ||
| 2025-04-04 | Calloway Nathaniel Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2025-04-04 | Calloway Nathaniel Director | Grant or award · Stock Option (right to buy) | +3,309 | 3,309 | ||
| 2025-04-04 | Lawler Joseph F. Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2025-04-04 | Lawler Joseph F. Director | Grant or award · Stock Option (right to buy) | +13,236 | 13,236 | ||
| 2025-04-04 | Aryeh Jason Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2025-04-04 | Aryeh Jason Director | Grant or award · Stock Option (right to buy) | +4,964 | 4,964 | ||
| 2025-04-04 | Lin Kenneth Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2025-04-04 | Lin Kenneth Director | Grant or award · Stock Option (right to buy) | +4,964 | 4,964 | ||
| 2025-04-04 | Cundy Kenneth C Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +115,037 | 115,037 | ||
| 2025-04-04 | SHAH BIMAL R. Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2025-04-04 | SHAH BIMAL R. Director | Grant or award · Stock Option (right to buy) | +6,618 | 6,618 | ||
| 2025-04-04 | English Aron R. Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2025-04-04 | English Aron R. Director | Grant or award · Stock Option (right to buy) | +2,647 | 2,647 | ||
| 2025-04-04 | Kupchyk Areta Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2025-04-04 | Kupchyk Areta Director | Grant or award · Stock Option (right to buy) | +2,647 | 2,647 | ||
| 2024-12-23 | English Aron R. Director | Purchase | +10,101,010 | $0.99 | $10.0M | 15,467,300 |
| 2024-12-09 | Cunningham, Richard Anthony Chief Executive Officer | Grant or award · Stock Option (right to buy) | +254,433 | 254,433 | ||
| 2024-06-13 | Calloway Nathaniel Director | Grant or award · Stock Option (right to buy) | +41,667 | 41,667 | ||
| 2024-06-13 | Calloway Nathaniel Director | Grant or award · Stock Option (right to buy) | +1,655 | 1,655 |
Page 1 of 3 · 59 trades